Ophthalmology · Spring Hill, FL
NPI
1962495457
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1180 Mariner Blvd
Spring Hill, FL, 34609
Phone (352) 683-7778
Groups this clinician bills Medicare through
Medicare paid, 2024
$344K
4,905 services
Medicare patients, 2024
2,348
Average age 78
Drug cost, 2024
$1.6M
3,341 prescriptions
Company payments, 2025
$1,961
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danielle Arcaro was code 92014 (ophthalmological e&m), 1,413 times for 1,409 patients. In total Danielle Arcaro billed 4,905 services in 24 codes, and Medicare paid $344K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,413 | 1,409 | $76.48 | $108K |
| 99214 Office E&M - Established | Office | 988 | 806 | $81.85 | $81K |
| 92133 Computerized Ophthalmic Imaging | Office | 695 | 693 | $23.80 | $17K |
| 99213 Office E&M - Established | Office | 570 | 455 | $59.34 | $34K |
| 92083 Vision, Hearing, and Speech Services | Office | 324 | 315 | $42.02 | $14K |
| 66821 Cataract Surgery | Office | 232 | 167 | $231.61 | $54K |
| 92250 Angiography | Office | 178 | 177 | $24.69 | $4,395 |
| 92004 Ophthalmological E&M | Office | 166 | 166 | $103.41 | $17K |
| 99204 Office E&M - New | Office | 80 | 80 | $108.09 | $8,647 |
| 76514 Ultrasound - Nonspecific | Office | 74 | 74 | $7.74 | $573 |
| 92134 Computerized Ophthalmic Imaging | Office | 60 | 59 | $26.10 | $1,566 |
| 99212 Office E&M - Established | Office | 47 | 47 | $39.78 | $1,870 |
| 92136 Ultrasound - Nonspecific | Office | 45 | 45 | $30.19 | $1,358 |
By year: 2022 $426K for 6,673 services; 2023 $377K for 5,366 services; 2024 $344K for 4,905 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danielle Arcaro prescribed most often to Medicare patients was Latanoprost, with 896 prescriptions and refills. In total Danielle Arcaro wrote 3,341 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 896 | 2,106 | 260 | $13K |
| Xdemvy Lotilaner | 620 | 947 | 615 | $1.1M |
| Brimonidine Tartrate Generic | 262 | 486 | 82 | $6,139 |
| Timolol Maleate Generic | 230 | 511 | 68 | $6,825 |
| Dorzolamide Hcl Generic | 181 | 402 | 64 | $4,083 |
| Restasis Cyclosporine | 147 | 267 | 59 | $160K |
| Ofloxacin Generic | 122 | 122 | 115 | $1,214 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 109 | 229 | 32 | $2,032 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 86 | 86 | 81 | $3,333 |
| Prednisolone Acetate Generic | 85 | 119 | 58 | $2,860 |
| Ketorolac Tromethamine Generic | 70 | 87 | 44 | $1,209 |
| Cyclosporine Generic | 43 | 89 | 17 | $27K |
| Lumigan Bimatoprost | 37 | 84 | 17 | $26K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 34 | 72 | Under 11 | $7,808 |
| Loteprednol Etabonate Generic | 30 | 40 | 23 | $5,124 |
Brand drugs: 1,570 claims; generic drugs: 1,771 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle Arcaro $1,961 ($1,961 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bausch & Lomb Americas Inc. with $583.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 8 | $583 |
| Tarsus Pharmaceuticals, Inc. TARS | 8 | $471 |
| Mallinckrodt Hospital Products Inc. | 3 | $203 |
| Amgen Inc. AMGN | 2 | $168 |
| Dompe US, Inc. | 3 | $161 |
| Alcon Vision LLC ALC | 5 | $131 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $125 |
| Harrow Eye, LLC | 2 | $42.61 |
| Astellas Pharma US Inc 4503.T | 1 | $27.8 |
| Genentech USA, Inc. ROG.SW | 1 | $25.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.